Trial Profile
Myocardial Perfusion Echocardiography to Detect Human Heart Transplant
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 31 Jul 2023
Price :
$35
*
At a glance
- Drugs Perflutren (Primary)
- Indications Heart transplant rejection
- Focus Therapeutic Use
- 26 Jul 2023 Status changed from recruiting to discontinued.
- 30 Jan 2018 Planned End Date changed from 1 Jul 2017 to 1 Dec 2019.
- 30 Jan 2018 Planned primary completion date changed from 1 Jul 2016 to 1 Dec 2019.